Skip to main content

Cumberland Pharmaceuticals Inc.

corporate_fare Company Profile

Cumberland Pharmaceuticals Inc.

CPIX·NASDAQ·Life Sciences·CIK 0001087294

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires, develops, and sells branded prescription pharmaceuticals. The company focuses on hospital acute care, gastroenterology, and oncology markets. Cumberland promotes its approved products in the United States through its hospital, field, and oncology sales divisions. It also works with international partners to register and provide its medicines to patients in other countries. Cumberland's portfolio of brands approved by the U.S. Food and Drug Administration (FDA) includes: * **Acetadote® (acetylcysteine) injection:** Used to treat acetaminophen poisoning. * **Caldolor® (ibuprofen) injection:** Used to treat pain and fever. * **Kristalose® (lactulose) oral solution:** A prescription laxative for constipation. * **Sancuso® (granisetron) transdermal:** Prevents nausea and vomiting in patients undergoing certain chemotherapy treatments. * **Vaprisol® (conivaptan) injection:** Raises serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia. * **Vibativ® (telavancin) injection:** Treats certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, and complicated skin and skin structure infections. * **Tacilia® (omeprazole, amoxicillin, and rifabutin) oral capsule:** Treats H. pylori infection. The company has also reported results from a clinical study of its ifetroban product candidate for cardiomyopathy associated with Duchenne muscular dystrophy (DMD).

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for CPIX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for CPIX spans 10-Q, 8-K, DEFM14A, PREM14A.

Recent high-impact activity:

  • Cumberland 10-Q: $80.6M Cash After Apotex Deal, Continuing Ops Still Burning $1.9M a Quarter
  • Cumberland Posts $77.8M Q3 Net Income on Divestiture Gain; $80.6M Cash
  • Cumberland Posts $77.8M Q3 Profit, Confirms Rolling NDA for DMD Cardiomyopathy
  • Cumberland to File Rolling NDA for Ifetroban in DMD Cardiomyopathy Despite FDA Efficacy Concerns
  • Cumberland Picks Rolling NDA Path for Ifetroban in DMD Heart Disease

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$44.52M
Net Income
-$2.84M
Diluted EPS
-$0.19
Op. Cash Flow
$4.93M
Free Cash Flow
$4.83M
Gross Profit
$37.85M
Operating Income
-$2.79M
Cash & Equivalents
$11.44M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
-6.4%
Shares Outstanding
14.96M sh
Source: 10-K · filed 2026-03-07 · accession 0001087294-26-000020

Short Interest & Short Volume

1.75 days to cover

FINRA reported short interest of 300,312 shares in CPIX as of the October 30, 2026 settlement, a 10.6% decrease from the prior period — about 1.8 days to cover at its recent average daily volume. On November 20, 2026, 36.7% of CPIX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)300,312 shares as of October 30, 2026
Change vs prior period▼ 10.6%
Days to cover1.75 at avg daily volume of 172,026
Daily short volume (FINRA facilities)36.7% of 62,540 shares on November 20, 2026
5-day average short volume56.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$5.74 -1.70% today
52-week range · as of 2026-11-13 $1.85 – $9.28
Market cap
$87.57M
Volume
124.6K (0.7× avg)
3-mo avg 188.8K
Live data · 2026-11-21 17:06 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CPIX - Latest Insights

CPIX
Nov 13, 2026, 5:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.89
Real-time Price: $5.74 info
Change: -$0.1492 (-3%) info
Market Cap: $87.574M info
CPIX
Nov 10, 2026, 5:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $5.74 info
Change: +$0.4408 (+8%) info
Market Cap: $87.574M info
CPIX
Nov 10, 2026, 4:00 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $5.74 info
Change: +$0.4408 (+8%) info
Market Cap: $87.574M info
CPIX
Oct 26, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.12
Real-time Price: $5.74 info
Change: +$0.6208 (+12%) info
Market Cap: $87.574M info
CPIX
Oct 26, 2026, 4:40 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.12
Real-time Price: $5.74 info
Change: +$0.6208 (+12%) info
Market Cap: $87.574M info
CPIX
Aug 07, 2026, 5:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.80
Real-time Price: $5.74 info
Change: -$2.06 (-26%) info
Market Cap: $87.574M info
CPIX
Aug 04, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.75
Real-time Price: $5.74 info
Change: -$2.01 (-26%) info
Market Cap: $87.574M info
CPIX
Aug 04, 2026, 5:06 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $7.75
Real-time Price: $5.74 info
Change: -$2.01 (-26%) info
Market Cap: $87.574M info
CPIX
Jul 13, 2026, 5:33 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.51
Real-time Price: $5.74 info
Change: -$0.7692 (-12%) info
Market Cap: $87.574M info
CPIX
Jul 13, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.51
Real-time Price: $5.74 info
Change: -$0.7692 (-12%) info
Market Cap: $87.574M info
CPIX
Jul 13, 2026, 11:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.13
Real-time Price: $5.74 info
Change: -$0.3842 (-6%) info
Market Cap: $87.574M info
CPIX
Jul 01, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.27
Real-time Price: $5.74 info
Change: -$1.53 (-21%) info
Market Cap: $87.574M info
CPIX
Jun 25, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.96
Real-time Price: $5.74 info
Change: -$0.2192 (-4%) info
Market Cap: $87.574M info
CPIX
Jun 02, 2026, 9:05 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $5.50
Real-time Price: $5.74 info
Change: +$0.2408 (+4%) info
Market Cap: $87.574M info
CPIX
May 26, 2026, 6:00 AM EDT
Filing Type: DEFM14A
Importance Score:
9
Price at Filing: $5.63
Real-time Price: $5.74 info
Change: +$0.1108 (+2%) info
Market Cap: $87.574M info
CPIX
May 15, 2026, 4:27 PM EDT
Filing Type: PREM14A
Importance Score:
9
Price at Filing: $4.95
Real-time Price: $5.74 info
Change: +$0.7908 (+16%) info
Market Cap: $87.574M info
CPIX
May 08, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $4.68
Real-time Price: $5.74 info
Change: +$1.06 (+23%) info
Market Cap: $87.574M info
CPIX
May 05, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.41
Real-time Price: $5.74 info
Change: +$1.33 (+30%) info
Market Cap: $87.574M info
CPIX
May 05, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.26
Real-time Price: $5.74 info
Change: +$1.48 (+35%) info
Market Cap: $87.574M info
CPIX
Apr 23, 2026, 9:02 AM EDT
Filing Type: DEFA14A
Importance Score:
10
Price at Filing: $5.04
Real-time Price: $5.74 info
Change: +$0.7008 (+14%) info
Market Cap: $87.574M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets